- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT05696626
Evaluatie van lasofoxifen in combinatie met abemaciclib in vergelijking met fulvestrant in combinatie met abemaciclib bij lokaal gevorderde of gemetastaseerde ER+/HER2-borstkanker met een ESR1-mutatie (ELAINEIII)
Een open-label, gerandomiseerd, multicenter onderzoek waarin de werkzaamheid en veiligheid van de combinatie van lasofoxifen en abemaciclib wordt vergeleken met de combinatie van fulvestrant en abemaciclib voor de behandeling van pre- en postmenopauzale vrouwen en mannen met lokaal gevorderde of gemetastaseerde ER+/HER2-borstkanker met een ESR1-mutatie
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation.
The main question the study aims to answer is:
• To compare the efficacy of the combination of lasofoxifene and abemaciclib with that of fulvestrant and abemaciclib Participants will receive either receive 5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day or the combination of fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day.
Studie Overzicht
Toestand
Conditie
Studietype
Inschrijving (Geschat)
Fase
- Fase 3
Contacten en locaties
Studiecontact
- Naam: Simon Daggett - Senior Vice President, Clinical Operations
- Telefoonnummer: (425) 620-8772 (909) 374-3793
- E-mail: clinicaltrials@leonabio.com
Studie Locaties
-
-
-
Blacktown, Australië
- Werving
- Blacktown Hospital
-
Contact:
- Jennifer Man
- E-mail: jennifer.man@health.nsw.gov.au
-
Concord, Australië
- Werving
- Concord Repatriation General Hospital
-
Contact:
- Belinda Kiely
- Telefoonnummer: +61 02 9767 6354
- E-mail: belinda.kiely@health.nsw.gov.au
-
South Brisbane, Australië
- Werving
- Mater Misericordiae Ltd, South Brisbane
-
Contact:
- Kathryn Middleton
- Telefoonnummer: +61 07 31632531
- E-mail: kathryn.middleton@mater.org.au
-
-
-
-
-
Brussels, België
- Werving
- Cliniques Universitaires Saint-Luc
-
Contact:
- Francois Duhoux
- Telefoonnummer: +32 2 764 51 06
- E-mail: francois.duhoux@saintluc.uclouvain.be
-
Edegem, België
- Ingetrokken
- Antwerp University Hospital (UZA)
-
Leuven, België
- Werving
- Universitaire Ziekenhuizen Leuven
-
Contact:
- Patrick Neven
- E-mail: patrick.neven@uzleuven.be
-
Namur, België
- Werving
- CHU UCL Namur - Site De Sainte-Elisabeth
-
Contact:
- Donatienne Taylor
- Telefoonnummer: 003281720524
- E-mail: donatienne.taylor@chuuclnamur.uclouvain.be; donatienne.taylor@uclouvain.be
-
-
-
-
Ontario
-
Ottawa, Ontario, Canada
- Werving
- The Ottawa General Hospital
-
Contact:
- Terry Ng
- E-mail: teng@toh.ca
-
Toronto, Ontario, Canada
- Werving
- Sunnybrook Health Sciences Centre -Bayview Campus
-
Contact:
- Rossanna Pezo
- Telefoonnummer: 416-480-4757
- E-mail: rossanna.pezo@sunnybrook.ca
-
-
Quebec
-
Montreal, Quebec, Canada
- Werving
- Lady Davis Institute for Medical Research Jewish General Hospital
-
Contact:
- Parvaneh Fallah
- E-mail: parvaneh.fallah@mail.mcgill.ca
-
Montreal, Quebec, Canada
- Werving
- Hospital Maisonneuve-Rosemont
-
Contact:
- Jonathan Noujaim
- E-mail: jonathan.noujaim.med@ssss.gouv.qc.ca
-
Saguenay, Quebec, Canada
- Ingetrokken
- CIUSSS du Saguenay-Lac-Saint-Jean
-
-
-
-
-
Anhui, China
- Werving
- Anhui Provincial Cancer Hospital
-
Contact:
- Yueyin Pan
- Telefoonnummer: 13805695536
- E-mail: yueyinpan1965@126.com
-
Anyang, China
- Werving
- Anyang Tumour Hospital
-
Contact:
- Junlan Guo
- E-mail: fanyuguo201@163.com
-
Beijing, China
- Werving
- Peking Union Medical College Hospital
-
Contact:
- Hongyan Ying
- Telefoonnummer: 15901226215
- E-mail: yhypumch@163.com
-
Beijing, China
- Werving
- Beijing Cancer Hospital
-
Contact:
- Huiping Li
- Telefoonnummer: 86 13811012595
- E-mail: huipingli2012@hotmail.com
-
Bengbu, China
- Werving
- The First Affiliated Hospital of Bengbu Medical University
-
Contact:
- Jinhai Zhu
- Telefoonnummer: 13956331545
- E-mail: bbmczhu@163.com
-
Changchun, China
- Werving
- The First Hospital of Jilin University
-
Contact:
- Dong Song
- Telefoonnummer: 13943189777
- E-mail: songdong117@126.com
-
Changsha, China
- Werving
- The Second Xiangya Hospital of Central South University
-
Contact:
- Wenjun Yi
- Telefoonnummer: 18608403318
- E-mail: Yiwenjun@csu.edu.cn
-
Chengdu, China
- Werving
- Sichuan Provincial People's Hospital
-
Contact:
- Jing Luo
- Telefoonnummer: 18981838521
- E-mail: 42635967@qq.com
-
Chengdu, China
- Werving
- West China Hospital, Sichuan University
-
Contact:
- Ting Luo
- Telefoonnummer: 18602866299
- E-mail: luoting@wchscu.cn
-
Chongqicun, China
- Werving
- The First Affiliated Hospital, Chongqing Medical University
-
Contact:
- Lu Gan
- Telefoonnummer: 18602320222
- E-mail: 914012118@qq.com
-
Dalian, China
- Werving
- The Second Hospital of Dalian Medical University
-
Contact:
- Man Li
- Telefoonnummer: 17709873580
- E-mail: dyeyliman@sohu.com
-
Deyang, China
- Werving
- Deyang People's Hospital
-
Contact:
- Ying Yi
- Telefoonnummer: 8618908103891
- E-mail: 23411004@qq.com
-
Fuyang, China
- Werving
- Fuyang Cancer Hosptial
-
Contact:
- Hesheng Qian
- Telefoonnummer: 13956814015
- E-mail: qianhesheng@sohu.com
-
Fuzhou, China
- Werving
- Fujian Cancer Hospital
-
Contact:
- Yi Zeng
- Telefoonnummer: 13905916886
- E-mail: zengyifc@126.com
-
Fuzhou, China
- Werving
- Fujian Medical University Union Hospital
-
Contact:
- Xiaoyan Lin
- Telefoonnummer: 13365910793
- E-mail: xiaoyanlin@yahoo.com
-
Guandong, China
- Werving
- Zhujiang Hospital of Nanfang Medical University
-
Contact:
- Guangyu Yao
- Telefoonnummer: 18675835626
- E-mail: ygy531@163.com
-
Guangdong, China
- Werving
- Guangdong Provincial People's Hospital
-
Contact:
- Kun Wang
- Telefoonnummer: 13922118086
- E-mail: gzwangkun@126.com
-
Guangdong, China
- Werving
- Meizhou People's Hospital
-
Contact:
- Jingna Wu
- Telefoonnummer: 13431819838
- E-mail: wujingna@mzrmyy.com
-
Guangdong, China
- Werving
- Peking University Shenzhen Hospital
-
Contact:
- Xiaoling Liu
-
Guangdong, China
- Werving
- Sun Yat-Sen University- Cancer Center
-
Contact:
- Shusen Wang
- Telefoonnummer: 13926168469
- E-mail: Wangshusench@yahoo.com.cn
-
Guangzhou, China
- Werving
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University
-
Contact:
- Yaping Yang
- Telefoonnummer: 13602409759
- E-mail: yypapple1225@163.com
-
Haikou, China
- Werving
- The First Affiliated Hospital of Hainan Medical University
-
Contact:
- Jinsheng Wu
- Telefoonnummer: 13707599070
- E-mail: wjs7911@126.com
-
Hangzhou, China
- Werving
- The First Affiliated Hospital, College of Medicine, Zhejiang University
-
Contact:
- Peifen Fu
- Telefoonnummer: 13958161556
- E-mail: fupeifen@hotmail.com
-
Hangzhou, China
- Werving
- Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
-
Contact:
- Xian Wang
- Telefoonnummer: 15857121122
- E-mail: wangxian@srrsh.com
-
Hangzhou, China
- Werving
- Zhejiang Provincial Hospital of Chinese Medicine
-
Contact:
- Xiaohong Xie
- Telefoonnummer: 13957101427
- E-mail: xxh666857@163.com
-
Hebei, China
- Werving
- Hebei Medical University - The Fourth Hospital - Hebei Provincial Tumor Hospital
-
Contact:
- Yunjiang Liu
- Telefoonnummer: 13703297890
- E-mail: lyj818326@163.com
-
Hubei, China
- Werving
- Xiangyang Central Hospital
-
Contact:
- Yuehua Wang
- Telefoonnummer: 13995777482
- E-mail: 510839835@qq.com
-
Hunan, China
- Werving
- Xiangya Hospital Central South University
-
Contact:
- Juan Huang
- Telefoonnummer: 13469081784
- E-mail: 375272151@qq.com
-
Jieyang, China
- Werving
- Jieyang People's Hospital
-
Contact:
- Zhenhai Cai
- Telefoonnummer: 13502606100
- E-mail: 462975632@qq.com
-
Jinan, China
- Werving
- Shandong Province Tumor Hospital
-
Contact:
- Yongqing Li
- Telefoonnummer: 15553115677
- E-mail: Liyq720917@126.com
-
Kunming, China
- Werving
- Yunnan Cancer Hospital
-
Contact:
- Wenlin Chen
- Telefoonnummer: 138 88087395
- E-mail: chenwenlin1@hotmail.com
-
Lanzhou, China
- Werving
- The First Hospital of Lanzhou University
-
Contact:
- Xiaoling Ling
- Telefoonnummer: 18693165668
- E-mail: 86860306@qq.com
-
Lanzhou, China
- Werving
- Gansu Provincial Hospital
-
Contact:
- Jie Hao
- Telefoonnummer: 13099203178
- E-mail: 523975396@qq.com
-
Linyi, China
- Werving
- Linyi Cancer Hospital
-
Contact:
- Jingfen Wang
- Telefoonnummer: 15963976026
- E-mail: 2298641960@qq.com
-
Luoyang, China
- Werving
- The First Affiliated Hospital of Henan University of Science and Technology
-
Contact:
- Xinshuai Wang
- Telefoonnummer: 13837986128
- E-mail: xshuaiw@126.com
-
Luoyang, China
- Werving
- Luoyang Central Hospital
-
Contact:
- Mingli Ni
- Telefoonnummer: 15803795310
- E-mail: 928718761@qq.com
-
Luzhou, China
- Werving
- The Affiliated Hospital of Southwest Medical University (Luzhou Medical College)
-
Contact:
- Lijia He
- Telefoonnummer: 13619042857
- E-mail: 908380148@qq.com
-
Nanchang, China
- Werving
- Jiangxi Cancer Hospital
-
Contact:
- Zhengkui Sun
- Telefoonnummer: 13907000210
- E-mail: sunzhengkui616@163.com
-
Nanchang, China
- Werving
- Nanchang People's Hospital
-
Contact:
- Chunwei Xie
- Telefoonnummer: 13006218563
- E-mail: 1875536028@qq.com
-
Nanjing, China
- Werving
- Nanjing Drum Tower Hospital
-
Contact:
- Li Xie
- Telefoonnummer: 13605169652
- E-mail: sherry01130@163.com
-
Nanjing, China
- Werving
- Jiangsu Province Hospital - The First Affiliated Hospital with Nanjing Medical University
-
Contact:
- Yongmei Yin
- Telefoonnummer: 86 13951842727
- E-mail: YongmeiYin_JSSRM@163.com
-
Nanning, China
- Werving
- Guangxi Medical University Cancer Hospital
-
Contact:
- Yan Liu
- Telefoonnummer: 15877129696
- E-mail: liuyansunny@163.com
-
Nanyang, China
- Werving
- Nanyang Central Hospital
-
Contact:
- Hao Zhang
- Telefoonnummer: 13703772883
- E-mail: nyzxyyzh@163.com
-
Neijiang, China
- Werving
- The Second People's Hospital of Neijiang
-
Contact:
- Xujuan Wang
- Telefoonnummer: 13696038558
- E-mail: 61132803@qq.com
-
Ningbo, China
- Werving
- Ningbo Medical Center Li Huili Hospital
-
Contact:
- WeiZhu Wu
- Telefoonnummer: 13957402451
- E-mail: 1144184462@qq.com
-
Pingdingshan, China
- Werving
- The First People'S Hospital of Ping Ding Shan
-
Contact:
- Xiaohui Jing
- E-mail: jingxh120@163.com
-
Qingdao, China
- Werving
- The Affiliated Hospital of Qingdao University
-
Contact:
- Haobo Wang
- Telefoonnummer: 18661805787
- E-mail: hbwangqy@126.com
-
Qingdao, China
- Werving
- Qingdao Central Hospital, University of Health and Rehabilitation Sciences
-
Contact:
- Qiang Mu
- Telefoonnummer: 18561858307
- E-mail: mudoctor@163.com
-
Quanzhou, China
- Werving
- Quanzhou First Hospital
-
Contact:
- Xiaofeng Li
- Telefoonnummer: 18965658239
- E-mail: 18965658239@189.cn
-
Shanghai, China
- Werving
- Huashan Hospital, Fudan University
-
Contact:
- Xiaohua Liang
- Telefoonnummer: 18121186232
- E-mail: xhliang66@sina.com
-
Shanghai, China
- Werving
- Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
-
Contact:
- GU Jianchun
- Telefoonnummer: 13764074162
- E-mail: gujianchun@126.com
-
Shang’ai, China
- Werving
- Fudan University Cancer Center
-
Contact:
- Zhimin Shao
- Telefoonnummer: 18017312288
- E-mail: szmgcp2016@163.com
-
Shanxi, China
- Werving
- First Affiliated Hospital of Xi'an Jiaotong University
-
Contact:
- Jin Yang
- Telefoonnummer: 18991232383
- E-mail: 1473106133@qq.com
-
Shaoyang, China
- Werving
- The Central Hospital of Shaoyang
-
Contact:
- Bin Dai
- Telefoonnummer: 15243901393
- E-mail: 490042498@qq.com
-
Shenyang, China
- Werving
- Liaoning Cancer Hospital & Institute
-
Contact:
- Tao Sun
- Telefoonnummer: 18900917877
- E-mail: lnzlrxnsy@163.com
-
Shouguang, China
- Werving
- Yuebei People's Hospital
-
Contact:
- Ruiwen Lei
- Telefoonnummer: 13826351682
- E-mail: leiruiwen2003@126.com
-
Sichuan, China
- Werving
- University of Electonic Science & Technology (UESTC) - Sichuan Cancer Hospital & Institute
-
Contact:
- Hao Wang
- Telefoonnummer: 13518204307
- E-mail: unique909@126.com
-
Tianjin, China
- Werving
- Tianjin Medical University Cancer Institute & Hospital
-
Contact:
- Yehui Shi
- Telefoonnummer: 18622221183
- E-mail: shiyehui@tjmuch.com
-
Tianjin, China
- Werving
- Tianjin Cancer Hospital Airport Hospital
-
Contact:
- Chunfang Hao
- Telefoonnummer: 13602031629
- E-mail: haochf@163.com
-
Wenzhou, China
- Werving
- The First Affiliated Hospital of Wenzhou Medical University
-
Contact:
- Ouchen Wang
- Telefoonnummer: 13957706099
- E-mail: woc099@163.com
-
Wuhan, China
- Werving
- Hubei Cancer Hospital
-
Contact:
- Xinhong Wu
- Telefoonnummer: 86 18602726300
- E-mail: xinhongwuhbch@163.com
-
Wuhan, China
- Werving
- Union Hospital Tongji Medical College Huazhong University of Science and Technolog
-
Contact:
- Jing Yao
- Telefoonnummer: 13971139665
- E-mail: Jeaneyph@163.com
-
Wuhu, China
- Werving
- The Second People's Hospital of WuHu
-
Contact:
- Hu Qin
- Telefoonnummer: 18055316155
- E-mail: huqin2007001@163.com
-
Xi Ail, China
- Werving
- The First Affiliated Hospital of Air Force Medical University
-
Contact:
- Jing Fan
- Telefoonnummer: 13572961081
- E-mail: jingfan@vip.163.com
-
Xiamen, China
- Werving
- Zhongshang Hospital Xiamen University
-
Contact:
- Minjun Meng
- E-mail: 31455216@qq.com
-
Xiamen, China
- Werving
- The first affiliated hospital of Xiamen University
-
Contact:
- Zhong Ouyang
- Telefoonnummer: 18205962909
- E-mail: oyzlyl@163.com
-
Xinzheng, China
- Werving
- The Second Affiliated Hospital Of Xi'an Jiaotong University
-
Contact:
- Shuqun Zhang
- Telefoonnummer: 13891841249
- E-mail: Zhangshuqun1971@aliyun.com
-
Xuzhou, China
- Werving
- The Affiliated Hospital of Xuzhou Medical University
-
Contact:
- Hongbing Wang
- Telefoonnummer: 15996969368
- E-mail: hbw0316@163.com
-
Xuzhou, China
- Werving
- Xuzhou Central Hospital
-
Contact:
- Li Sun
- Telefoonnummer: 18052230275
- E-mail: xzsonya@sohu.com
-
Yuncheng, China
- Werving
- Yuncheng Central Hospital
-
Contact:
- Xiaoke Hou
- Telefoonnummer: 17703591026
- E-mail: hxk13720980018@163.com
-
Zhejiang, China
- Werving
- Zhejiang Provincial People's Hospital
-
Contact:
- Xuli Meng
- Telefoonnummer: 13757128803
- E-mail: mxlmail@126.com
-
Zhejiang, China
- Werving
- Zhejiang cancer hospital
-
Contact:
- Junqing Chen
- Telefoonnummer: 18658840965
- E-mail: 10918129@zju.edu.cn
-
Zhengzhou, China
- Werving
- Henan Cancer Hospital
-
Contact:
- Zhenzhen Liu
- Telefoonnummer: 13603862755
- E-mail: liuzhenzhen73@126.com
-
Zhengzhou, China
- Werving
- The First Affiliated Hospital of Zhengzhou University
-
Contact:
- Jingruo Li
- Telefoonnummer: 13939021305
- E-mail: jingruoli@163.com
-
Zhongshan, China
- Werving
- Zhongshan City People's Hospital
-
Contact:
- Shihui Ma
- Telefoonnummer: 13620394254
- E-mail: shihui612@163.com
-
Zhumadian, China
- Werving
- Zhumadian Central Hospital
-
Contact:
- Sen Xiang
- Telefoonnummer: 13839928053
- E-mail: xiangsen7@163.com
-
Ürümqi, China
- Werving
- The Affiliated Cancer Hospital of Xinjiang Medical University
-
Contact:
- Bing Zhao
- Telefoonnummer: 13899908184
- E-mail: 819502412@qq.com
-
-
-
-
-
Dresden, Duitsland
- Werving
- Universitaetsklinikum Carl Gustav Carus Dresden
-
Contact:
- Pauline Wimberger
- Telefoonnummer: +49 (0)351 458-6728
- E-mail: pauline.wimberger@uniklinikum-dresden.de
-
München, Duitsland
- Werving
- Klinikum rechts der Isar der Technischen Universitaet Muenchen
-
Contact:
- Evelyn Klein
- Telefoonnummer: 089 4140 2433
- E-mail: evelyn.klein@tum.de
-
-
-
-
-
Avignon, Frankrijk, 84000
- Werving
- Institut Sainte Catherine
-
Contact:
- Julien Grenier
- E-mail: j.grenier@isc84.org
-
Besançon, Frankrijk
- Werving
- Service d'Oncologie Medicale - CHRU Besancon
-
Contact:
- Laura Mansi
- E-mail: lmansi@chu-besancon.fr
-
Bordeaux, Frankrijk
- Werving
- Institut Bergonie
-
Contact:
- Marc Debled
- Telefoonnummer: +33 (0)5 56 33 04 77
- E-mail: M.Debled@bordeaux.unicancer.fr
-
Caen, Frankrijk
- Werving
- Centre Francois Baclesse
-
Contact:
- George Emile
- E-mail: g.emile@baclesse.unicancer.fr
-
Le Mans, Frankrijk, 72015
- Werving
- Groupement de Cooperation Sanitaire (GCS) ELSAN - Clinique Victor Hugo
-
Contact:
- Sophie Roche
- E-mail: essaisroche@ilcgroupe.fr
-
Lille, Frankrijk
- Werving
- Centre Oscar Lambret
-
Contact:
- Charlotte Bellier
- Telefoonnummer: +33 (0)3.20.29.59.59
- E-mail: investigation@o-lambret.fr;c-bellier@o-lambret.fr
-
Lyon, Frankrijk
- Werving
- Centre Leon Berard
-
Contact:
- Thomas Bachelot
- Telefoonnummer: +33 4 78 78 26 54
- E-mail: thomas.bachelot@lyon.unicancer.fr
-
Marseille, Frankrijk
- Werving
- Institut Paoli-Calmettes
-
Contact:
- Alexandre Tassin de Nonneville
- Telefoonnummer: +33491223789
- E-mail: tassindenonnevillea@ipc.unicancer.fr
-
Pierre-Bénite, Frankrijk, 69310
- Werving
- HCL Centre Hospitalier Lyon Sud
-
Contact:
- Julien Peron
- E-mail: julien.peron@chu-lyon.fr
-
Poitiers, Frankrijk
- Werving
- CHU Poitiers - Pole Regional de Cancerologie de Poitiers (PRC)
-
Contact:
- Nicolas Isambert
- E-mail: nicolas.isambert@chu-poitiers.fr
-
Rouen, Frankrijk
- Werving
- Centre Henri Becquerel
-
Contact:
- Marianne Leheurteur
- E-mail: marianne.leheurteur@chb.unicancer.fr
-
Toulouse, Frankrijk
- Werving
- Institut Claudius Regaud
-
Contact:
- Florence Dalenc
- Telefoonnummer: (+33) 5 31 15 51 22
- E-mail: dalenc.florence@iuct-oncopole.fr
-
Villejuif, Frankrijk, 94800
- Werving
- Institut Gustave Roussy
-
Contact:
- Alessandro Viansone
- E-mail: Alessandro.viansone@gustaveroussy.fr
-
-
-
-
-
Afula, Israël, 1834111
- Werving
- Haemek Medical Center
-
Contact:
- Gil Bar-Sela
- E-mail: gil_ba@clalit.org.il
-
Beersheba, Israël, 8486614
- Werving
- Soroka Medical Center
-
Contact:
- Wael Hozaeel
- E-mail: waelhz@clalit.org.il
-
Haifa, Israël
- Werving
- Rambam Health Care Campus
-
Contact:
- Ayelet Shai
- E-mail: A_SHAI@rambam.health.gov.il
-
Jerusalem, Israël
- Werving
- Shaare Zedek Medical Center
-
Contact:
- Ora Solange Rosengarten
- E-mail: rosengarten@szmc.org.il
-
Jerusalem, Israël
- Werving
- Hadassah Ein-Karem Medical Center
-
Contact:
- Ofra Maimon
- Telefoonnummer: +972505172570
- E-mail: ofra406@hadassah.org.il
-
Kfar Saba, Israël, 4428164
- Werving
- Meir Medical Center
-
Contact:
- Iryna Kuchuk
- E-mail: iryna.kuchuk@clalit.org.il
-
Petah Tikva, Israël
- Werving
- Rabin MC
-
Contact:
- Rinat Yerushalmi
- E-mail: rinaty@clalit.org.il
-
Rehovot, Israël
- Werving
- Kaplan Medical Center
-
Contact:
- Adi Rasco
- Telefoonnummer: 972-524610814
- E-mail: adifar@clalit.org.il
-
Tel Aviv, Israël
- Werving
- Tel Aviv Sourasky Medical Center
-
Contact:
- Amir Sonnenblick
- E-mail: amirson@tlvmc.gov.il
-
Tel HaShomer, Israël
- Werving
- Sheba Medical Center
-
Contact:
- Einav Nili Gal-Yam
- Telefoonnummer: +972-3-5302243
- E-mail: Einav.NiliGal-Yam@sheba.health.gov.il
-
-
-
-
-
Ancona, Italië
- Werving
- Azienda Ospedaliero-Universitaria delle Marche
-
Contact:
- Rossana Berardi
- E-mail: rossana.berardi@ospedaliriuniti.marche.it
-
Aviano, Italië
- Werving
- Centro Riferimento Oncologico - Aviano
-
Contact:
- Lorenzo Gerratana
- Telefoonnummer: (+39) 0434 659254
- E-mail: lgerratana@gmail.com; lorenzo.gerratana@cro.it
-
Candiolo, Italië, 10060
- Werving
- La Fondazione e l'Istituto di Candiolo
-
Contact:
- Vanesa Gregorc
- E-mail: vanesa.gregorc@ircc.it
-
Meldola, Italië
- Werving
- IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori - IRST S.r.l.
-
Contact:
- Michela Palleschi
- Telefoonnummer: +39 0543 739100
- E-mail: michela.palleschi@irst.emr.it
-
Milan, Italië
- Werving
- Istituto Europeo di Oncologia
-
Contact:
- Marco Angelo Colleoni
- Telefoonnummer: 02-57489.970
- E-mail: marco.colleoni@ieo.it; emilia.montagna@ieo.it
-
Misterbianco, Italië
- Werving
- Humanitas Istituto Clinico Catanese
-
Contact:
- Maria Vita Sanò
- Telefoonnummer: 09573390197
- E-mail: maria.vita_sano@ccocatania.it
-
Modena, Italië
- Werving
- Azienda Ospedaliero-Universitaria di Modena
-
Contact:
- Luca Moscetti
- Telefoonnummer: +390594223244
- E-mail: moscetti.luca@aou.mo.it
-
Naples, Italië
- Werving
- Istituto Nazionale Tumori IRCCS Fondazione G. Pascale
-
Contact:
- Michelino De Laurentiis
- Telefoonnummer: +3908117770442
- E-mail: delauren@breastunit.org; m.delaurentiis@istitutotumori.na.it
-
Novara, Italië, 28100
- Ingetrokken
- Azienda Ospedaliero Universitaria Maggiore Della Carita
-
Padova, Italië, 35128
- Werving
- Istituto Oncologico Veneto-I.R.C.C.S. - Ospedale Busonera
-
Contact:
- Valentina Guarneri
- E-mail: valentina.guarneri@unipd.it
-
Parma, Italië
- Werving
- Azienda Ospedaliero Universitaria di Parma
-
Contact:
- Benedetta Pellegrino
- E-mail: benedetta.pellegrino@unipr.it
-
Contact:
- E-mail: bpellegrino@ao.pr.it
-
Pavia, Italië
- Werving
- Fondazione IRCCS Policlinico San Matteo
-
Hoofdonderzoeker:
- Gianpiero Rizzo
-
Contact:
- Gianpiero Rizzo
- E-mail: g.rizzo@smatteo.pv.it
-
Roma, Italië
- Werving
- Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore
-
Contact:
- Emilio Bria
- Telefoonnummer: +390630155202
- E-mail: emiliobria@yahoo.it; emilio.bria@policlinicogemelli.it
-
Verona, Italië
- Voltooid
- Azienda Ospedaliera Universitaria Integrata Verona-Ospedale Borgo Trento
-
-
-
-
-
Biała Podlaska, Polen
- Ingetrokken
- KO - MED Centra Kliniczne Sp. z o.o., Wojewodzki Szpital Specjalistyczny w Bialej Podlaskiej
-
Gliwice, Polen
- Ingetrokken
- Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Oddzial w Gliwicach, I Klinika Radioterapii i Chemioterapii
-
Krakow, Polen
- Werving
- Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie - Oddzial Onkologii Klinicznej z Pododdzialem Dziennym
-
Contact:
- Anna Kowalczyk-Tekiela
- Telefoonnummer: +48 502 315 790
- E-mail: atekiela@interia.pl
-
Krakow, Polen
- Werving
- SP ZOZ Szpital Uniwersytecki w Krakowie, Oddzial Onkologii Klinicznej
-
Contact:
- Piotr Wysocki
- Telefoonnummer: 48 12 424-89-12
- E-mail: piotr.wysocki@uj.edu.pl; klinikaonkologii@su.krakow.pl
-
Lodz, Polen
- Voltooid
- Instytut Centrum Zdrowia Matki Polki - Klinika Onkologii
-
Poznan, Polen
- Werving
- Uniwersytecki Szpital Kliniczny w Poznaniu, Oddzial Chemioterapii
-
Contact:
- Rodryg Ramlau
- Telefoonnummer: +48513155613
- E-mail: rramlau@gmail.com
-
Poznan, Polen
- Werving
- Wielkopolskie Centrum Onkologii (WCO) / The Greater Poland Cancer Center
-
Contact:
- Anna Szafryna-Kliwicka
- Telefoonnummer: +48618850620
- E-mail: anna.szafryna-kliwicka@wco.pl
-
Wieliszew, Polen
- Werving
- Mazowiecki Szpital Onkologiczny
-
Contact:
- Sylwina Socha
- Telefoonnummer: 134 +48 22 766 15 00
- E-mail: s.socha@szpitalonkologiczny.pl
-
-
-
-
-
Bucharest, Roemenië
- Werving
- Memorial Healthcare International SRL
-
Contact:
- Ingrid Iordan
- Telefoonnummer: 0721298677
- E-mail: mireliordan@yahoo.com
-
Bucharest, Roemenië
- Ingetrokken
- Centrul Medical Focus
-
Cluj-Napoca, Roemenië
- Werving
- Radiotherapy Center Cluj
-
Contact:
- Andrei Ungureanu
- Telefoonnummer: +40742206212
- E-mail: andreiungureanu.oncolog@yahoo.com
-
Craiova, Roemenië
- Werving
- Oncology Center Sfantul Nectarie
-
Contact:
- Michael Schenker
- Telefoonnummer: +40351401336
- E-mail: mike_schenker@yahoo.com
-
Craiova, Roemenië
- Voltooid
- Onco Clinic Consult SA
-
Piteşti, Roemenië
- Werving
- Gral Medical SRL
-
Contact:
- Adela-Luiza Chirila
- Telefoonnummer: +40766442720
- E-mail: dr.adela_chirila@yahoo.com
-
Timișoara, Roemenië
- Werving
- OncoMed Oncology Center
-
Contact:
- Daniela Sirbu
- Telefoonnummer: +40 0744571617
- E-mail: desirbu@yahoo.com
-
-
-
-
-
Singapore, Singapore, 329563
- Werving
- Curie Oncology
-
Contact:
- Su-Mien Lynette Ngo
- Telefoonnummer: +6562595538
- E-mail: lynettengo@curieoncology.com.sg
-
-
-
-
-
Barcelona, Spanje
- Werving
- Hospital Universitario Vall d'Hebron
-
Contact:
- Miriam Arumi de Dios
- Telefoonnummer: +34600240679
- E-mail: marumi@vhio.net
-
Barcelona, Spanje
- Werving
- Hospital Clinic Barcelona
-
Contact:
- Tomas Pascual
- E-mail: topascual@clinic.cat
-
Córdoba, Spanje
- Werving
- Hospital Universitario Reina Sofia
-
Contact:
- Juan de la Haba
- E-mail: juahaba@gmail.com
-
Madrid, Spanje, 28034
- Werving
- Hospital Universitario Ramon y Cajal
-
Contact:
- Noelia Martinez Jañez
- E-mail: mjnoelia@hotmail.com
-
Madrid, Spanje, 28040
- Werving
- Hospital Fundacion Jimenez Diaz
-
Contact:
- Yann Izarzugaza
- E-mail: yizarzugaza@quironsalud.es
-
Madrid, Spanje
- Werving
- Hospital Universitario 12 de Octubre
-
Contact:
- Eva Ciruelos Gil
- Telefoonnummer: +34913908000
- E-mail: evaciruelos.h12o@gmail.com
-
Madrid, Spanje
- Werving
- Hospital Universitario de La Princesa
-
Contact:
- Ana Isabel Ballesteros
- Telefoonnummer: +34915202200
- E-mail: oncologiamedica.princesa@outlook.com
-
Madrid, Spanje
- Werving
- Clinica Universidad de Navarra - Madrid
-
Contact:
- Jaime Espinos Jimenez
- E-mail: jespinos@unav.es
-
Madrid, Spanje
- Werving
- Hospital Beata Maria Ana
-
Contact:
- Javier Cortes Castan
- Telefoonnummer: +34 935 460 139
- E-mail: javierr.cortes@maj3.health
-
Madrid, Spanje
- Werving
- Hospital General Universitario Gregorio Maranon
-
Contact:
- Sara Lopez- Tarruella Cobo
- E-mail: slopeztarruella@gmail.com
-
Málaga, Spanje
- Werving
- Hospital Regional Universitario de Malaga
-
Contact:
- Begoña Jimenez Rodríguez
- E-mail: bego.jimenez@ibima.eu
-
Contact:
- E-mail: begojrodriguez@gmail.com
-
Pamplona, Spanje
- Werving
- Clinica Universidad de Navarra - Pamplona
-
Contact:
- Jaime Espinos Jimenez
- E-mail: jespinos@unav.es
-
Valencia, Spanje
- Werving
- Instituto Valenciano de Oncologia
-
Contact:
- Angel Guerrero Zotano
- Telefoonnummer: +34 96 111 4051
- E-mail: aguerrero@fivo.org
-
-
-
-
-
Changhua, Taiwan
- Werving
- Changhua Christian Hospital (CCH)
-
Contact:
- Shou-Tung Chen
- E-mail: 1886@cch.org.tw
-
Kaohsiung City, Taiwan
- Werving
- Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH)
-
Contact:
- Ming-Feng Hou
- E-mail: mifeho@kmu.edu.tw
-
Tainan, Taiwan
- Werving
- National Cheng Kung University Hospital
-
Contact:
- Wei-Pang Chung
- Telefoonnummer: +886975014242
- E-mail: edgarbun@gmail.com
-
Taipei, Taiwan
- Werving
- National Taiwan University Hospital
-
Contact:
- Chiun-Sheng Huang
- E-mail: huangcs@ntu.edu.tw
-
Taipei, Taiwan
- Werving
- Tri-Service General Hospital
-
Contact:
- Ming-Shen Dai
- Telefoonnummer: +886-2-87927208
- E-mail: dms1201@gmail.com
-
Taipei, Taiwan
- Werving
- Koo Foundation Sun Yat-Sen Cancer Center
-
Contact:
- Chi-Feng Chung
- E-mail: cheh@kfsyscc.org
-
Taoyuan City, Taiwan
- Werving
- Linkou Chang Gung Memorial Hospital (CGMHLK)
-
Contact:
- Chi-Chang Yu
- E-mail: kenneth0609@cgmh.org.tw
-
-
-
-
-
Ankara, Turkije (Türkiye)
- Werving
- Ankara University Medical Faculty Medical Oncology Department
-
Contact:
- Arzu Yasar
- E-mail: hayasar@ankara.edu.tr
-
Bursa, Turkije (Türkiye)
- Werving
- Uludag University Faculty of Medicine Hospital
-
Contact:
- Turkkan Evrensel
- E-mail: evrensel@uludag.edu.tr
-
Edirne, Turkije (Türkiye)
- Werving
- Trakya University Medical Faculty Hospital
-
Contact:
- Sernaz Topaloglu
- E-mail: sernaz.uzunoglu@gmail.com
-
Izmir, Turkije (Türkiye)
- Werving
- Medical Point Izmir Hospital
-
Contact:
- Cagatay Arslan
- E-mail: arslancagatay@yahoo.com
-
-
Ankara
-
Çankaya, Ankara, Turkije (Türkiye)
- Werving
- Liv Hospital Ankara
-
Contact:
- Saadettin Kilickap
- E-mail: skilickap@yahoo.com
-
-
Istanbul
-
Kadiköy, Istanbul, Turkije (Türkiye)
- Werving
- Goztepe Prof. Dr. Suleyman Yalcin City Hospital
-
Contact:
- Mahmut Gumus
- E-mail: mgumus@superonline.com
-
Çapa, Istanbul, Turkije (Türkiye)
- Werving
- Istanbul University CAPA Medical Faculty
-
Contact:
- Meltem Ekenel
- E-mail: meltemekenel@yahoo.com
-
-
Kocaeli
-
İzmit, Kocaeli, Turkije (Türkiye)
- Werving
- Kocaeli University Research and Application Hospital
-
Contact:
- Devrim Cabuk
- E-mail: devrim.cabuk@kocaeli.edu.tr
-
Contact:
- E-mail: devrimcabuk@yahoo.com
-
-
İzmir
-
Bornova, İzmir, Turkije (Türkiye)
- Werving
- Ege University Medical Faculty Hospital
-
Contact:
- Burcu Cakar
- E-mail: burcu.cakar@gmail.com
-
Konak, İzmir, Turkije (Türkiye)
- Werving
- Suat Seren Training and Research Hospital
-
Contact:
- Sema Erturk
- E-mail: drsemaerturk@gmail.com
-
-
-
-
-
Cardiff, Verenigd Koninkrijk, CF14 2TL
- Werving
- Velindre Cancer Center
-
Contact:
- Simon Waters
- E-mail: simon.waters@wales.nhs.uk
-
Harlow, Verenigd Koninkrijk, CM20 1QX
- Werving
- Princess Alexandra Hospital - Harlow
-
Contact:
- Apostolos Konstantis
- E-mail: a.konstantis@nhs.net
-
Leeds, Verenigd Koninkrijk
- Werving
- Leeds Teaching Hospitals NHS Trust
-
Contact:
- Chris Twelves
- E-mail: C.J.Twelves@leeds.ac.uk
-
London, Verenigd Koninkrijk
- Werving
- Charing Cross Hospital
-
Contact:
- Farah Rehman
- E-mail: f.rehman@nhs.net
-
London, Verenigd Koninkrijk, NW3 2
- Werving
- Royal Free London NHS Foundation Trust
-
Contact:
- Judy King
- E-mail: judy.king@nhs.net
-
Manchester, Verenigd Koninkrijk
- Werving
- The Christie NHS Foundation Trust
-
Contact:
- Anne Armstrong
- E-mail: anne.armstrong3@nhs.net
-
Milton Keynes, Verenigd Koninkrijk, MK6 5LD
- Werving
- Milton Keynes Hospital
-
Contact:
- Azhar Rizvi
- E-mail: azhar.rizvi@mkuh.nhs.net
-
Nottingham, Verenigd Koninkrijk
- Werving
- Nottingham City Hospital
-
Contact:
- Sarah Khan
- E-mail: sarah.khan69@nhs.net
-
Stockton-on-Tees, Verenigd Koninkrijk, TS198PE
- Ingetrokken
- University Hospital of North Tees
-
-
-
-
Arizona
-
Scottsdale, Arizona, Verenigde Staten, 85259
- Werving
- Mayo Clinic - Scottsdale
-
Contact:
- Clinical Trials Office - All Mayo Clinic Locations
- Telefoonnummer: 855-776-0015
-
Tucson, Arizona, Verenigde Staten, 85719
- Werving
- University of Arizona - Cancer Center
-
Contact:
- Umbreen Rozell
- E-mail: uarshad@arizona.edu
-
-
California
-
Santa Rosa, California, Verenigde Staten, 95403
- Werving
- Providence Medical Foundation - Santa Rosa, CA
-
Contact:
- Jarrod Holmes
- E-mail: jarrod.holmes@stjoe.org
-
-
Florida
-
Jacksonville, Florida, Verenigde Staten, 32224
- Werving
- Mayo Clinic - Jacksonville
-
Contact:
- Clinical Trials Office - All Mayo Clinic Locations
- Telefoonnummer: 855-776-0015
-
Miami, Florida, Verenigde Staten, 33143
- Werving
- Miami Cancer Institute
-
Contact:
- Ana Sandoval Leon
- E-mail: AnaSand@baptisthealth.net
-
Plantation, Florida, Verenigde Staten, 33324
- Werving
- Miami Cancer Institute Plantation
-
Contact:
- Ana Sandoval Leon
- E-mail: AnaSand@baptisthealth.net
-
-
Georgia
-
Atlanta, Georgia, Verenigde Staten, 30322
- Werving
- Emory University School of Medicine
-
Contact:
- Jane Meisel
- E-mail: jane.l.meisel@emory.edu
-
-
Kentucky
-
Louisville, Kentucky, Verenigde Staten, 40202
- Werving
- Norton Cancer Institute
-
Contact:
- Laila Agrawal
- E-mail: laila.agrawal@nortonhealthcare.org
-
-
Maryland
-
Baltimore, Maryland, Verenigde Staten, 21231
- Werving
- Johns Hopkins Kimmel Cancer Center
-
Contact:
- Jessica Tao
- E-mail: jtao10@jhmi.edu
-
-
Massachusetts
-
Boston, Massachusetts, Verenigde Staten, 02114
- Werving
- Massachusetts General Hospital
-
Contact:
- Seth Wander
- E-mail: SWANDER@mgh.harvard.edu
-
Boston, Massachusetts, Verenigde Staten, 02215
- Voltooid
- Beth Israel Deaconess Medical Center
-
Boston, Massachusetts, Verenigde Staten, 02115
- Werving
- Dana-Farber Cancer Institute
-
Contact:
- Erica Mayer
- E-mail: erica_mayer@dfci.harvard.edu
-
-
Michigan
-
Grand Rapids, Michigan, Verenigde Staten, 49503
- Werving
- Cancer and Hematology Centers of Western Michigan
-
Contact:
- Amy Vander Woude
- E-mail: avanderwoude@chcwm.com
-
-
Minnesota
-
Minneapolis, Minnesota, Verenigde Staten, 55407
- Voltooid
- Allina Health System DBA Virginia Piper Cancer Institute
-
Rochester, Minnesota, Verenigde Staten, 55905
- Werving
- Mayo Clinic - Rochester
-
Contact:
- Clinical Trials Office - All Mayo Clinic Locations
- Telefoonnummer: 855-776-0015
-
-
Missouri
-
Kansas City, Missouri, Verenigde Staten, 64111
- Werving
- Saint Luke's Cancer Institute
-
Contact:
- Timothy Pluard
- Telefoonnummer: 816-932-3300
- E-mail: tpluard@saint-lukes.org
-
St Louis, Missouri, Verenigde Staten, 63110
- Werving
- Washington University School of Medicine
-
Contact:
- Nusayba Bagegni
- E-mail: nbagegni@wustl.edu
-
-
Nevada
-
Reno, Nevada, Verenigde Staten, 89502
- Werving
- Renown Regional Medical Centre
-
Contact:
- Lee Schwartzberg
- E-mail: Lee.Schwartzberg@renown.org
-
Reno, Nevada, Verenigde Staten, 89511-2250
- Werving
- Cancer Care Specialists
-
Contact:
- Sowjanya Reganti
- E-mail: sreganti@ccsreno.com
-
-
New Jersey
-
Belleville, New Jersey, Verenigde Staten, 07109
- Ingetrokken
- New Jersey Cancer Care, PA
-
New Brunswick, New Jersey, Verenigde Staten, 08901
- Werving
- Rutgers Cancer Institute of New Jersey
-
Contact:
- Coral Omene
- E-mail: co273@cinj.rutgers.edu
-
-
New Mexico
-
Albuquerque, New Mexico, Verenigde Staten, 87110
- Nog niet aan het werven
- Presbyterian Kaseman Hospital
-
Contact:
- Ethan Binder
- E-mail: ebinder@phs.org
-
Rio Rancho, New Mexico, Verenigde Staten, 87124
- Werving
- Presbyterian Rust Cancer Center
-
Contact:
- Ethan Binder
- E-mail: ebinder@phs.org
-
-
New York
-
New York, New York, Verenigde Staten, 10029
- Werving
- Icahn School of Medicine at Mount Sinai
-
Contact:
- Amy Tiersten
- E-mail: amy.tiersten@mssm.edu
-
New York, New York, Verenigde Staten, 10065
- Werving
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
-
Contact:
- Sherry Shen
- E-mail: shens1@mskcc.org
-
New York, New York, Verenigde Staten, 10011
- Werving
- The Blavatnik Family - Chelsea Medical Center at Mount Sinai
-
Contact:
- Amy Tiersten
- Telefoonnummer: (212) 241-3300
- E-mail: amy.tiersten@mssm.edu
-
-
North Carolina
-
Durham, North Carolina, Verenigde Staten, 27705
- Werving
- Duke University Medical Center
-
Contact:
- Rani Bansal
- Telefoonnummer: 919-660-1278
- E-mail: rani.bansal@duke.edu
-
-
North Dakota
-
Grand Forks, North Dakota, Verenigde Staten, 58201
- Voltooid
- Altru Health Systems
-
-
Ohio
-
Cleveland, Ohio, Verenigde Staten, 44106
- Werving
- University Hospitals Seidman Cancer Center
-
Contact:
- Takae Mizukami
- E-mail: Takae.Mizukami@UHhospitals.org
-
Cleveland, Ohio, Verenigde Staten, 44119
- Ingetrokken
- Cleveland Clinic
-
Columbus, Ohio, Verenigde Staten, 42112
- Werving
- The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (OSUCCC - James)
-
Contact:
- Daniel Stover
- E-mail: Daniel.Stover@osumc.edu
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Verenigde Staten, 15232
- Voltooid
- University of Pittsburgh Medical Center
-
-
Texas
-
Houston, Texas, Verenigde Staten, 77030
- Werving
- Baylor College of Medicine
-
Contact:
- Ahmed Elkhanany
- E-mail: Ahmed.Elkhanany@bcm.edu
-
Houston, Texas, Verenigde Staten, 77030
- Werving
- MD Anderson Cancer Center
-
Contact:
- Senthil Damodaran
- E-mail: SDamodaran@mdanderson.org
-
Houston, Texas, Verenigde Staten, 77054
- Werving
- Harris Health System - Smith Clinic
-
Hoofdonderzoeker:
- Ahmed Elkhanany
-
Contact:
- Ahmed Elkhanany
- E-mail: Ahmed.Elkhanany@bcm.edu
-
-
Washington
-
Seattle, Washington, Verenigde Staten, 98104
- Ingetrokken
- Swedish Cancer Institute (SCI)
-
-
-
-
-
Gyeonggi-do, Zuid -Korea
- Werving
- National Cancer Center
-
Contact:
- Keun Seok Lee
- E-mail: kslee@ncc.re.kr
-
Jeollanam-do, Zuid -Korea, 58128
- Werving
- Chonnam National University Hwasun Hospital
-
Contact:
- Hyun Jeong Shim
- Telefoonnummer: 82-61-379-7634
- E-mail: hjnhj@chonnam.ac.kr
-
Seoul, Zuid -Korea
- Werving
- Korea University Anam Hospital
-
Contact:
- Kyong Hwa Park
- Telefoonnummer: 82-2-920-6841
- E-mail: khpark@korea.ac.kr
-
Seoul, Zuid -Korea
- Ingetrokken
- Severance Hospital, Yonsei University Health System
-
Seoul, Zuid -Korea
- Ingetrokken
- Asan Medical Center
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
-
Pre- or postmenopausal women or men.
-
Locally advanced and/or metastatic ER+ breast cancer with radiological or clinical evidence of progression on an AI in combination with either palbociclib or ribociclib as their first hormonal treatment for metastatic disease.
-
Histological or cytological confirmation of ER+/HER2 - disease
-
No evidence of progression for at least 6 months on an AI/CDKi combination for advanced breast cancer.
-
At least 1 or more ESR1 point mutations in the ESR1 ligand binding domain as assessed in cell- free ctDNA obtained from a blood or breast cancer tissue.
-
Locally advanced or metastatic breast cancer with at least 1 measurable (according to RECIST 1.1) lesion with or without non-measurable lesions.
-
Subjects may have received 1 cytotoxic chemotherapy regimen in the metastatic disease setting prior to study entry, but must have recovered from chemotherapy acute toxicity excluding alopecia and Grade 2 peripheral neuropathy.
-
Eastern Cooperative Oncology Group (ECOG) performance score of 0 or 1
-
Adequate organ function
-
Able to swallow tablets
-
Brain metastases are allowed only if the following 4 parameters hold:
- Asymptomatic,
- Definitively treated (e.g., radiotherapy, surgery),
- Not requiring steroids up to 4 weeks before study treatment initiation, AND
- Central nervous system disease stable for >3 months prior to registration as documented by magnetic resonance imagining (MRI).
-
Able to understand and voluntarily sign a written informed consent before any screening procedures.
-
Every attempt should be made to obtain a biopsy of metastatic breast cancer tissue, when safe and feasible, to provide histological or cytological confirmation of ER+/HER2- disease as assessed by a local laboratory, according to American Society of Clinical Oncology/College of American Pathologists guidelines, using slides, paraffin blocks, or paraffin samples. If a biopsy is done, it may undergo genomic testing at some point to assess for ESR1 mutations and correlation with ctDNA results. If a biopsy is not possible or inappropriate from a clinical standpoint, the ER and HER2 status from the subject's most recent biopsy must confirm that the subject is ER+ and HER2
Exclusion Criteria:
- Lymphangitic carcinomatosis involving the lung.
- History of Grade 3 or Grade 4 interstitial lung disease (ILD) on previous therapy.
- Visceral crisis in need of cytotoxic chemotherapy as assessed by the investigator.
- Prior progression of disease on abemaciclib, fulvestrant, or other selective estrogen receptor degrader (SERD) therapy.
- Subjects with a known hypersensitivity to fulvestrant or to any of the excipients
- Radiotherapy within 30 days prior to Visit 0 (Day 1) except in case of localized radiotherapy for analgesic purposes or for lytic lesions at risk of fracture, which can then be completed within 7 days prior to Visit 0 (Day 1). Subjects must have recovered from radiotherapy toxicities prior to Visit 0 (Day 1).
- Known RB1 mutations or deletions that in the opinion of the investigator confer resistance to CDK4/6i. (Screening for RB1 mutation is not required for entry.)
- History of long QTc (Q-T interval corrected for heart rate) syndrome or a QTc of >480 msec.
- History of a pulmonary embolus (PE), deep vein thrombosis (DVT), or any known thrombophilia, unless the event occurred greater than 6 months prior to screening and the subject is treated with chronic anticoagulant therapy such as apixaban (Eliquis) or rivaroxaban (Xarelto).
- Lasofoxifene is not recommended for use in subjects with conditions that place them at increased risk for VTEs (such as severe congestive heart failure [CHF] or prolonged immobilization).
- On concomitant strong CYP3A4 inhibitors.
- On strong and moderate CYP3A4 inducers.
- Any significant co-morbidity that would impact the study or the subject's safety, including subjects with significant malabsorption.
- Active systemic bacterial or fungal infection (requiring intravenous [IV] antibiotics or antifungals at the time of initiating study treatment).
- Known infection with human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis C virus (HCV).
- History of malignancy within the past 5 years (excluding breast cancer), except basal cell or squamous cell carcinoma of the skin curatively treated by surgery.
- Positive serum pregnancy test (only if premenopausal).
- Sexually active premenopausal women and men unwilling to use double-barrier contraception.
- Women who are breast feeding
- History of non-compliance to medical regimens.
- Unwilling or unable to comply with the protocol.
- Current participation in any clinical research trial involving an investigational drug or device within the last 30 days.
- Subjects with a history of familial hypertriglyceridemia or fasting triglyceride levels >880 mg/dL at screening.
- Fasting triglyceride level >300 mg/dL and ≤880 mg/dL at screening. Subjects may be retested and enrolled if they have a repeat fasting triglyceride level less than or equal to 300 mg/dL prior to enrollment (e.g., after adjustment with diet and/or treatment).
- Fasting cholesterol level >400 mg/dL at screening. Subjects may be retested and enrolled if they have a repeat fasting cholesterol level less than or equal to 400 mg/dL prior to enrollment (e.g., after adjustment with diet and/or treatment).
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Treatment
Pre- and Postmenopausal Women and Men with locally advanced or metastatic ER+/HER2- breast cancer who have disease progression on an AI in combination with either palbociclib or ribociclib as their first hormonal treatment for metastatic disease and who have an ESR1 mutation. |
5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day |
|
Actieve vergelijker: Reference Therapy
Pre- and Postmenopausal Women and Men with locally advanced or metastatic ER+/HER2- breast cancer who have disease progression on an AI in combination with either palbociclib or ribociclib as their first hormonal treatment for metastatic disease and who have an ESR1 mutation. |
Fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Progression free survival (PFS)
Tijdsspanne: Within approximately 3 years
|
PFS is defined as the time from the date of randomization [Visit 0 (Day 1)] to the earliest date of first documented progression per RECIST 1.1 as determined by BICR or death due to any cause. |
Within approximately 3 years
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Objective response rate (ORR)
Tijdsspanne: Within approximately 3 years
|
ORR is defined as the percentage of subjects with measurable disease at baseline whose best overall response is either a confirmed CR or a confirmed PR according to RECIST 1.1. |
Within approximately 3 years
|
|
Overall survival (OS)
Tijdsspanne: Within approximately 3 years
|
Overall survival is defined as time from the date of Visit 0 (Day 1) to death due to any cause. |
Within approximately 3 years
|
|
Clinical benefit rate (CBR)
Tijdsspanne: Within approximately 3 years
|
CBR is defined as the percentage of subjects with best overall response of confirmed CR, confirmed PR, or stable disease (SD) with a duration of 24 weeks or longer according to RECIST 1.1. As used in this calculation, stable disease is defined as stable disease in those subjects with measurable disease plus nonPR/non progressive disease (PD) in subjects with non-measurable disease. |
Within approximately 3 years
|
|
Duration of response (DoR) in subjects with an objective response
Tijdsspanne: Within approximately 3 years
|
DoR is from the date of first documented confirmed response (CR or PR) to the date of first documented progression of disease or death due to any cause, whichever is earlier. |
Within approximately 3 years
|
|
Time to response (TTR) in subjects with an objective response
Tijdsspanne: Within approximately 3 years
|
TTR is from the date of randomization to the date of first documented confirmed response (CR or PR). |
Within approximately 3 years
|
|
Time to cytotoxic chemotherapy
Tijdsspanne: Within approximately 3 years
|
From the date of randomization to the date of first documented use of cytotoxic chemotherapy. |
Within approximately 3 years
|
|
Quality of Life (QoL) evaluated using the Functional Assessment of Cancer Therapy-Breast Cancer-Endocrine Subscale (FACT B-ES)
Tijdsspanne: Within approximately 3 years
|
Scale ranges from 'Not at all' to 'Very much' |
Within approximately 3 years
|
|
Incidence of Adverse Events (AEs) and Serious AEs
Tijdsspanne: Within approximately 3 years
|
The type, severity (graded by Common Terminology Criteria for Adverse Events [CTCAE version 5.0]), course, duration, seriousness, and relationship to study treatment will be assessed at each visit |
Within approximately 3 years
|
Medewerkers en onderzoekers
Sponsor
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
- Neoplasmata per site
- Neoplasmata
- Huidziektes
- Borst ziekten
- Huid- en bindweefselaandoeningen
- Borstneoplasmata
- Hormonen
- Hormonen, hormoonvervangers en hormoonantagonisten
- Polycyclische verbindingen
- Steroïden
- Verbindingen met gefuseerde ring
- Estradiol
- Woest
- Estranes
- Estradiol -congeners
- Gonadale steroïde hormonen
- Gonadale hormonen
- Fulvestrant
- abemaciclib
- Lasofoxifeen
Andere studie-ID-nummers
- SMX 22-002
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .